D-Index & Metrics Best Publications
Donald C. Sheppard

Donald C. Sheppard

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 50 Citations 8,108 112 World Ranking 2189 National Ranking 62

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Bacteria

His primary scientific interests are in Microbiology, Corpus albicans, Candida albicans, Fungal protein and Bacterial adhesin. His studies in Microbiology integrate themes in fields like Biosynthesis, Biofilm, Biochemistry, Human pathogen and Virulence. Donald C. Sheppard interconnects Pseudomonas aeruginosa, Glycoside hydrolase, Enzyme and Antimicrobial in the investigation of issues within Biofilm.

His research investigates the connection between Virulence and topics such as Aspergillus fumigatus that intersect with issues in Gene, Galactosaminogalactan and Aspergillus. His work in Candida albicans tackles topics such as Cell biology which are related to areas like Endocytosis, Transcription factor and Endothelial stem cell. His Fungal protein research incorporates themes from Molecular biology, Cadherin, Chinese hamster ovary cell and Host cell surface.

His most cited work include:

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline (417 citations)
  • Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host Cells (412 citations)
  • Complementary adhesin function in C. albicans biofilm formation. (245 citations)

What are the main themes of his work throughout his whole career to date?

Donald C. Sheppard mainly investigates Microbiology, Aspergillus fumigatus, Virulence, Biofilm and Aspergillosis. Donald C. Sheppard works in the field of Microbiology, focusing on Candida albicans in particular. His biological study spans a wide range of topics, including Polysaccharide, Pathogenesis, Galactosaminogalactan and Hypha.

His work is dedicated to discovering how Virulence, In vitro are connected with In vivo and other disciplines. His Biofilm research incorporates elements of Pseudomonas aeruginosa, Biosynthesis and Glycoside hydrolase. His Aspergillosis research also works with subjects such as

  • Aspergillus which connect with Disease,
  • Voriconazole and related Amphotericin B and Internal medicine.

He most often published in these fields:

  • Microbiology (70.07%)
  • Aspergillus fumigatus (49.66%)
  • Virulence (25.85%)

What were the highlights of his more recent work (between 2018-2021)?

  • Aspergillus fumigatus (49.66%)
  • Microbiology (70.07%)
  • Galactosaminogalactan (24.49%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Aspergillus fumigatus, Microbiology, Galactosaminogalactan, Virulence and Mutant. His Aspergillus fumigatus research focuses on Pathogenesis and how it connects with Review article, Disease and Aspergillosis. As part of the same scientific family, Donald C. Sheppard usually focuses on Microbiology, concentrating on Immune system and intersecting with Pathogen.

His Galactosaminogalactan study combines topics from a wide range of disciplines, such as Platelet, Innate immune system and Biofilm. His Conidiation study, which is part of a larger body of work in Virulence, is frequently linked to Thiamine pyrophosphate, bridging the gap between disciplines. His Mutant research includes elements of Cell wall and Siderophore.

Between 2018 and 2021, his most popular works were:

  • Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. (121 citations)
  • Threats Posed by the Fungal Kingdom to Humans, Wildlife, and Agriculture. (45 citations)
  • Circulating (1→3)-β-D-Glucan is associated with immune activation during HIV infection (25 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Bacteria

The scientist’s investigation covers issues in Galactosaminogalactan, Aspergillus fumigatus, Immunology, Biofilm and Biofilm matrix. His Galactosaminogalactan study necessitates a more in-depth grasp of Virulence. His Virulence study which covers Aspergillosis that intersects with Disease.

His Immunology study typically links adjacent topics like Chromosomal translocation. As part of one scientific family, Donald C. Sheppard deals mainly with the area of Biofilm, narrowing it down to issues related to the Virulence factor, and often Microbiology, Carbohydrate-binding module and Operon. Donald C. Sheppard has included themes like Hydrolase, Protein structure, Biochemistry, Pseudomonas aeruginosa and Glycoside hydrolase in his Biofilm matrix study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host Cells

Quynh T Phan;Carter L Myers;Yue Fu;Yue Fu;Donald C Sheppard.
PLOS Biology (2007)

568 Citations

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning.
Clinical Microbiology and Infection (2018)

563 Citations

Complementary adhesin function in C. albicans biofilm formation.

Clarissa J. Nobile;Heather A. Schneider;Jeniel E. Nett;Donald C. Sheppard.
Current Biology (2008)

367 Citations

Functional and Structural Diversity in the Als Protein Family of Candida albicans

Donald C. Sheppard;Michael R. Yeaman;William H. Welch;Quynh T. Phan.
Journal of Biological Chemistry (2004)

347 Citations

Fungal invasion of normally non-phagocytic host cells.

Scott G Filler;Donald C Sheppard.
PLOS Pathogens (2006)

321 Citations

Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway

Yue Fu;Ashraf S. Ibrahim;Ashraf S. Ibrahim;Donald C. Sheppard;Yee-Chun Chen.
Molecular Microbiology (2002)

288 Citations

The Role of Mast Cells in the Defence against Pathogens

Mirjam Urb;Donald C. Sheppard.
PLOS Pathogens (2012)

246 Citations

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis

Michel Laverdière;Richard G. Lalonde;Jean Guy Baril;Donald C. Sheppard.
Journal of Antimicrobial Chemotherapy (2006)

237 Citations

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.

Paul E. Verweij;Michelle Ananda-Rajah;David Andes;Maiken C. Arendrup.
Drug Resistance Updates (2015)

235 Citations

Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis

Hyunsook Park;Carter L. Myers;Donald C. Sheppard;Quynh T. Phan.
Cellular Microbiology (2004)

204 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Donald C. Sheppard

Scott G. Filler

Scott G. Filler

University of California, Los Angeles

Publications: 161

Ashraf S. Ibrahim

Ashraf S. Ibrahim

University of California, Los Angeles

Publications: 89

Bernhard Hube

Bernhard Hube

Leibniz Association

Publications: 89

John E. Edwards

John E. Edwards

University of California, Los Angeles

Publications: 63

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 63

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 57

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 51

Nathan P. Wiederhold

Nathan P. Wiederhold

The University of Texas Health Science Center at San Antonio

Publications: 44

Michael R. Yeaman

Michael R. Yeaman

University of California, Los Angeles

Publications: 41

David R. Andes

David R. Andes

University of Wisconsin–Madison

Publications: 40

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 39

Anne Puel

Anne Puel

Rockefeller University

Publications: 39

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 39

Axel A. Brakhage

Axel A. Brakhage

Leibniz Association

Publications: 38

Aaron P. Mitchell

Aaron P. Mitchell

University of Georgia

Publications: 37

Jean-Paul Latgé

Jean-Paul Latgé

Institut Pasteur

Publications: 37

Trending Scientists

Douglas S. Reeves

Douglas S. Reeves

North Carolina State University

Adam Wierman

Adam Wierman

California Institute of Technology

Robert J. Webster

Robert J. Webster

Vanderbilt University

Christophe Clanet

Christophe Clanet

École Polytechnique

Harry Partridge

Harry Partridge

Ames Research Center

Richard L. Maas

Richard L. Maas

Brigham and Women's Hospital

Davide Cammarano

Davide Cammarano

Purdue University System

Virginia Espina

Virginia Espina

George Mason University

Elizabeth L. Hartland

Elizabeth L. Hartland

Hudson Institute of Medical Research

Conrad Childs

Conrad Childs

University College Dublin

Alan R. Palmer

Alan R. Palmer

University of Nottingham

Paolo Bartolomeo

Paolo Bartolomeo

Allen Institute for Brain Science

Pieter H. Reitsma

Pieter H. Reitsma

Leiden University

Jean-François Emile

Jean-François Emile

University of Paris-Saclay

John B. Holcomb

John B. Holcomb

The University of Texas Health Science Center at Houston

Hedy L. Kindler

Hedy L. Kindler

University of Chicago

Something went wrong. Please try again later.